Cure My Disease

Don't miss your cure!

 Log in / Sign up

Did pandemic waves reshape stroke treatment? a Pan-European study investigates

NCT ID NCT07795021

Knowledge-focused Sponsor: Dr. Yaroslav Winter Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 31, 2026 · Last updated Sep 01, 2026 · Updated 1 time

Summary

This study examines how hospital admissions and treatments for stroke and transient ischemic attack (TIA) changed during the COVID-19 pandemic across Europe. Researchers will collect data from about 40 stroke units, covering admissions, length of stay, and procedures like thrombolysis and thrombectomy from January 2019 to June 2021. They will compare patterns between the first and later pandemic waves and look at regional factors like population density and COVID-19 rates. The goal is to identify which areas were most affected and what factors influenced stroke care delivery.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
This analysis could reveal how pandemics disrupt stroke care, helping hospitals prepare for future health crises and maintain timely treatment.
What could go wrong
The study relies on hospital statistics, so data quality may vary across sites. It describes patterns, not causes, and cannot prove why changes occurred.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 40,000 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jul 2026

Expected to finish

Oct 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

All patients admitted for stroke or TIA to the participating stroke units between January 1, 2019, and June 30, 2021.

Ages

Children (under 18), adults (18 to 64) and older adults (65 and over)

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: stroke transient ischemic attack Exclusion Criteria: traumatic cause of stroke

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Hemorrhagic stroke are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hemorrhagic stroke ischemic stroke stroke disorder transient ischemic attack

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Stroke (CVA) or tia

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    4 sites in 4 countries. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Departement of Neurology 1st Medical Faculty and General Teaching Hospital

    RECRUITING

    Prague, Czechia

  • UOC Neurologia, ASST Papa Giovanni XXIII

    RECRUITING

    Bergamo, Italy

  • University Hospital Mainz

    RECRUITING

    Mainz, Germany

  • University of Barcelona, Comprehensive Stroke Center, Hospital Clinic

    RECRUITING

    Barcelona, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.